BizWest: Vivaldi Biosciences, a biopharmaceutical company that works out of a facility at Colorado State University, has received a grant from Flu Lab to evaluate the potential of its DeltaFLU universal influenza vaccine, administered by nasal spray, to block flu virus transmission and spread of infection and disease.

link